CRISPR Therapeutics CFO reports stock option holdings
One listed restricted stock unit award specifies quarterly vesting on March 10, 2024, March 10, 2025, March 10, 2026, and March 10, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
CRISPR Therapeutics AG (CRSP) lists Chief Financial Officer Andrew Jacob Silver’s directly held stock options and restricted stock units. The options include 4,892 Common Shares at a $35.59 exercise price, expiring November 1, 2028, and 18,734 Common Shares at a $42.12 exercise price, expiring March 14, 2035. The report also lists 1,300 restricted stock units tied to an award with quarterly vesting through March 10, 2027.
Insider Trade Summary
22 transactions reported
Mixed
22 txns
Insider
Silver Andrew Jacob
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F8 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F10 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Stock Option ( Right to Buy) F12 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F13 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F14 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F15 | -- | -- | -- |
| holding | Restricted Stock Units F17, F16 | -- | -- | -- |
| holding | Restricted Stock Units F17, F18 | -- | -- | -- |
| holding | Restricted Stock Units F17, F19 | -- | -- | -- |
| holding | Restricted Stock Units F17, F20 | -- | -- | -- |
| holding | Restricted Stock Units F17, F21 | -- | -- | -- |
| holding | Restricted Stock Units F17, F22 | -- | -- | -- |
| holding | Restricted Stock Units F17, F23 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 85,374 contracts (Direct);
Stock Option ( Right to Buy) — 3,766 contracts (Direct);
Restricted Stock Units — 65,127 contracts (Direct)
Footnotes (23)
- F1. This option was granted on November 1, 2018 with respect to 10,000 Common Shares. 25% of the shares vested on November 1, 2019, with the remaining shares vested in 48 equal monthly installments thereafter.
- F2. This option was granted on October 22, 2019 with respect to 1,716 Common Shares. 100% of the shares vested in 48 equal monthly installments, with the first installment vested on November 22, 2019.
- F3. This option was granted on March 10, 2020 with respect to 3,960 Common Shares. 100% of the shares vested in 48 equal monthly installments, with the first installment vested on April 10, 2020.
- F4. This option was granted on October 5, 2020 with respect to 1,800 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 5, 2020.
- F5. This option was granted on March 11, 2021 with respect to 4,522 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on April 11, 2021.
- F6. This option was granted on October 15, 2021 with respect to 1,966 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 15, 2021.
- F7. This option was granted on February 18, 2022 with respect to 3,840 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on March 18, 2022.
- F8. This option was granted on October 7, 2022 with respect to 2,366 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 7, 2022.
- F9. This option was granted on March 10, 2023 with respect to 8,431 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on April 10, 2023.
- F10. This option was granted on October 13, 2023 with respect to 3,766 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 13, 2023.
- F11. This option was granted on March 20, 2024 with respect to 9,039 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on April 20, 2024.
- F12. This option was granted on October 16, 2024 with respect to 3,766 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 16, 2024.
- F13. This option was granted on March 14, 2025 with respect to 18,734 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on April 14, 2025.
- F14. This option was granted on October 3, 2025 with respect to 6,944 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on November 3, 2025.
- F15. This option was granted on March 20, 2026 with respect to 14,874 Common Shares. 100% of the shares vest in 48 equal monthly installments, with the first installment vested on April 20, 2026.
- F16. This restricted stock unit award was granted on March 10, 2023 with respect to 5,202 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.
- F17. Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- F18. This restricted stock unit award was granted on March 20, 2024 with respect to 6,780 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.
- F19. This restricted stock unit award was granted on December 18, 2024 with respect to 15,000 Common Shares, with 100% of the shares vesting on December 18, 2027.
- F20. This restricted stock unit award was granted on March 14, 2025 with respect to 11,250 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.
- F21. This restricted stock unit award was granted on December 16, 2025 with respect to 12,000 Common Shares, with 100% of the shares vesting on December 16, 2028.
- F22. This restricted stock unit award was granted on March 20, 2026 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027, (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030.
- F23. This restricted stock unit award was granted on May 29, 2026 with respect to 10,000 Common Shares, with 100% of the shares vesting on November 29, 2028.
Key Figures
Underlying Common Shares for options expiring November 1, 2028: 4,892 shares
Exercise price for options expiring November 1, 2028: $35.59 per share
Underlying Common Shares for options expiring March 14, 2035: 18,734 shares
+3 more
6 metrics
Underlying Common Shares for options expiring November 1, 2028
4,892 shares
Directly held stock option
Exercise price for options expiring November 1, 2028
$35.59 per share
Directly held stock option
Underlying Common Shares for options expiring March 14, 2035
18,734 shares
Directly held stock option
Exercise price for options expiring March 14, 2035
$42.12 per share
Directly held stock option
Restricted stock units
1,300 units
Directly held; associated with an award granted March 10, 2023
Expiration date for options covering 18,734 Common Shares
March 14, 2035
Directly held stock option
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, contingent right
3 terms
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
Restricted Stock Units financial
"Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do Andrew Jacob Silver’s 1,300 CRSP restricted stock units vest?
The 1,300 reported restricted stock units are associated with an award granted March 10, 2023. The award schedule provides for one quarter to vest on March 10, 2024, March 10, 2025, March 10, 2026, and March 10, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
